DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Atkins MB, McDermott DF, Powles T. et al.
IMmotion150: A phase II trial in untreated metastatic renal cell carcinoma (mRCC) patients (pts) of atezolizumab (atezo) and bevacizumab (bev) vs and following atezo or sunitinib (sun).
JCI 2017;
35: 4505
We do not assume any responsibility for the contents of the web pages of other providers.